Predictive Effect of Interleukin-1β on All-Cause Mortality in Patients with Acute Myocardial Infarction

Abstract Objective To evaluate the predictive effect of interleukin-1β (IL-1β) on all-cause mortality in patients with acute myocardial infarction (AMI). Methods A total of 331 patients admitted to the Chest Pain Center of Mindong Hospital Affiliated to Fujian Medical University for AMI from September 2022 to October 2024 were analyzed retrospectively. The patients were classified into 4 groups according to the quartile of the serum IL-1β. Cox regression analysis, Kaplan-Meier method, restricted cubic spline (RCS) analysis, and receiver operating characteristic (ROC) curve analysis were used to examine the correlation between IL-1β and the risk of all-cause mortality. Results After a median follow-up of 13 months, 24 (7.3%) individuals experienced all-cause mortality. There were 3 (3.7%), 2 (2.4%), 3 (3.6%), and 16 (19.5%) deaths in the first, second, third, and fourth quartile group, respectively. Kaplan-Meier analysis showed that compared with the first, second, and third quartile groups, the number of all-cause mortality in the fourth quartile group increased (log-rank test P = .003). Multivariate Cox regression analysis showed that after the adjusted for other factors, compared to the patients in the first quartile group, the patients in the fourth quartile group were at the highest risk of all-cause mortality (Hazard Ratio = 5.82; 95% CI, 1.45-23.30; P = .013). Restricted cubic spline analysis showed that IL-1β was linearly associated with all-course mortality risk (Poverall<0.001, Pnonlinear = 0.421). Receiver operating characteristic curve analysis demonstrated that the area under the curve of IL-1β for prediction of all-cause mortality was 0.774 (95% CI, 0.626-0.881), with a sensitivity of 63.6% and a specificity of 91.2%. Conclusions Interleukin-1β is significantly associated with an increased risk of all-cause mortality in patients with AMI. IL-1β can predict the risk of all-cause mortality in patients with AMI.

Authors

Institutions

Publication Details

Journal
American Journal of Hypertension
Published
2026-06-16
DOI
https://doi.org/10.1093/ajh/hpaf194
Primary Topic
Adipokines, Inflammation, and Metabolic Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predictive Effect of Interleukin-1β on All-Cause Mortality in Patients with Acute Myocardial Infarction

Z Zhang, X Y Liu, X LI, Lijuan Zheng et al.
American Journal of Hypertension
Adipokines, Inflammation, and Metabolic Diseases
article

Predictive Effect of Interleukin-1β on All-Cause Mortality in Patients with Acute Myocardial Infarction

Z Zhang, X Y Liu, X LI, Lijuan Zheng, Wensheng Yang, Yanzhou Zhu, Fengming Huang, Ye Chunxiang, Lei Huabing, Liao Ziqi, Xie Jianhua, Fan Jinmao, Ling Jie
article en

Abstract

Abstract Objective To evaluate the predictive effect of interleukin-1β (IL-1β) on all-cause mortality in patients with acute myocardial infarction (AMI). Methods A total of 331 patients admitted to the Chest Pain Center of Mindong Hospital Affiliated to Fujian Medical University for AMI from September 2022 to October 2024 were analyzed retrospectively. The patients were classified into 4 groups according to the quartile of the serum IL-1β. Cox regression analysis, Kaplan-Meier method, restricted cubic spline (RCS) analysis, and receiver operating characteristic (ROC) curve analysis were used to examine the correlation between IL-1β and the risk of all-cause mortality. Results After a median follow-up of 13 months, 24 (7.3%) individuals experienced all-cause mortality. There were 3 (3.7%), 2 (2.4%), 3 (3.6%), and 16 (19.5%) deaths in the first, second, third, and fourth quartile group, respectively. Kaplan-Meier analysis showed that compared with the first, second, and third quartile groups, the number of all-cause mortality in the fourth quartile group increased (log-rank test P = .003). Multivariate Cox regression analysis showed that after the adjusted for other factors, compared to the patients in the first quartile group, the patients in the fourth quartile group were at the highest risk of all-cause mortality (Hazard Ratio = 5.82; 95% CI, 1.45-23.30; P = .013). Restricted cubic spline analysis showed that IL-1β was linearly associated with all-course mortality risk (Poverall<0.001, Pnonlinear = 0.421). Receiver operating characteristic curve analysis demonstrated that the area under the curve of IL-1β for prediction of all-cause mortality was 0.774 (95% CI, 0.626-0.881), with a sensitivity of 63.6% and a specificity of 91.2%. Conclusions Interleukin-1β is significantly associated with an increased risk of all-cause mortality in patients with AMI. IL-1β can predict the risk of all-cause mortality in patients with AMI.

American Journal of HypertensionVol. 39(7)
Fujian Medical University (CN), First Affiliated Hospital of Fujian Medical University (CN), Second Affiliated Hospital of Fujian Medical University (CN)
Good health and well-being
Openalex Percentile: Top 7%
Adipokines, Inflammation, and Metabolic Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.